Don Parsons

Don Parsons is an accomplished professional in pharmaceutical development with extensive experience in leading analytical and technical development in the biotechnology and pharmaceutical sectors. Currently serving as Head of Early Technical Development and LNP Process Development and Head of Drug Product Process Sciences at Moderna Therapeutics since October 2016, Don has previously held positions including Vice President of Pharmaceutical Development and Senior Director of Chemistry at BIND Therapeutics, where responsibilities encompassed the development of targeted nanoparticle drug delivery systems and critical platform technologies. Prior roles at BIND Biosciences, Warner Chilcott, and Procter & Gamble further highlight expertise in analytical development, method validation, and manufacturing processes. Don holds a PhD in Chemistry from the University of Wisconsin-Madison and an AB, Cum Laude with Honors, in Chemistry from Dartmouth College.